New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 25, 2014
16:08 EDTHPTXHyperion says EMA to review of marketing authorization application for RAVICTI
Hyperion Therapeutics announced that the European Medicines Agency has completed technical and content validation and accepted the filing of the Marketing Authorisation Application for RAVICTI Oral Liquid for the treatment of urea cycle disorders. Acceptance of the MAA confirms that the submission is complete so as to permit a substantive review by the Rapporteurs and the Committee for Medicinal Products for Human Use. "We are very pleased to receive MAA acceptance for review of RAVICTI and anticipate a CHMP opinion in the third quarter of 2015," said Hyperion CEO Donald Santel.
News For HPTX From The Last 14 Days
Check below for free stories on HPTX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 10, 2014
07:54 EDTHPTXHyperion Therapeutics price target lowered to $38 from $43 at Cantor
Subscribe for More Information
September 9, 2014
09:08 EDTHPTXHyperion Therapeutics weakness creates buying opportunity, says JMP Securities
Subscribe for More Information
September 8, 2014
12:18 EDTHPTXOn The Fly: Midday Wrap
Subscribe for More Information
10:49 EDTHPTXHyperion Therapeutics program end removes catalyst, says Leerink
Leerink says Hyperion Therapeutics' termination of its DiaPep277 program removes a near-term catalyst and potential upside driver. The firm reiterates an Outperform rating on the stock, however, noting the Ravicti base business remains strong.
10:40 EDTHPTXHyperion Therapeutics drops on termination of DiaPep277 program
Subscribe for More Information
09:12 EDTHPTXOn The Fly: Pre-market Movers
Subscribe for More Information
08:03 EDTHPTXHyperion terminates DiaPep277 program, finds misconduct by Andromeda Biotech
Subscribe for More Information
08:01 EDTHPTXHyperion terminates DiaPep277 program, finds misconduct by Andromeda Biotech
Subscribe for More Information
07:51 EDTHPTXHyperion Therapeutics trading halted, pending news
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use